Asset Details
Do you wish to reserve the book?
Antiepileptic Drugs 2012: Recent Advances and Trends
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Antiepileptic Drugs 2012: Recent Advances and Trends
Do you wish to request the book?
Antiepileptic Drugs 2012: Recent Advances and Trends
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Antiepileptic Drugs 2012: Recent Advances and Trends
2012
Overview
There are now 24 antiepileptic drugs (AEDs) approved for use in epilepsy in the United States by the Food and Drug Administration. A literature search was conducted using PubMed, MEDLINE, and Google for all English-language articles that discuss newly approved AEDs and the use of AEDs in epilepsy in the United States from January 1, 2008, through December 31, 2011. Five new agents were identified that have come onto the market within the past 2 years. Moreover, 3 trends involving AEDs have become clinically important and must be considered by all who treat patients with epilepsy. These trends include issues of generic substitution of AEDs, pharmacogenomics predicting serious adverse events in certain ethnic populations, and the issue of the suicide risk involving the entire class of AEDs. This article discusses the most recent AEDs approved for use in the United States and the 3 important trends shaping the modern medical management of epilepsy.
Publisher
Elsevier Inc,Mayo Foundation,Elsevier, Inc,Elsevier Limited
Subject
/ Anticonvulsants - adverse effects
/ Anticonvulsants - therapeutic use
/ Anticonvulsants. Antiepileptics. Antiparkinson agents
/ Biological and medical sciences
/ Complications and side effects
/ Epilepsy
/ Humans
/ Licensing, certification and accreditation
/ Pharmacology. Drug treatments
/ Review
